Why yes, yes it is a problem!
The Biopharmaceutical Industry Provides 75% Of The FDA’s Drug Review Budget. Is This A Problem?
Are you suggesting that he who pays the fiddler might call the tune?
Inconceivable!
Key line in that article:
“charges were levied on pharmaceutical companies for each new drug application (NDA) filed. “
So the “funding” is an application fee. You want to market your product great here’s the application that’s $2000 for us to even do a review.